Treatment strategies for drug-exposed neonates

Clinics in Perinatology

Volumn 26, Issue 1, 1999, Pages 231-243

  Kandall, S R ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; COCAINE; CODEINE; DEXTROPROPOXYPHENE; DIAMORPHINE; DIAZEPAM; ETHCHLORVYNOL; GLUTETHIMIDE; HYDROXYZINE; METHADONE; METHAMPHETAMINE; MORPHINE; NALOXONE; OPIATE; PAREGORIC; PENTAZOCINE; PETHIDINE; PHENCYCLIDINE; PHENOBARBITAL;

ANAMNESIS; HUMAN; IRRITABILITY; NEUROTOXICITY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SEIZURE; SUBSTANCE ABUSE; SYMPTOMATOLOGY; VOMITING; WITHDRAWAL SYNDROME;

EID: 0032926642     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30081-2     Document Type: Review

References (68)

1. AAP Task Force on Infant Positioning and SIDS: Positioning and SIDS Pediatrics 89 1992 1120
2. Athinarayanan P. Pierog S.H. Nigam S.K. Chlordiazepoxide withdrawal in the neonate Am J Obstet Gynecol 124 1976 212
3. Blinick G. Inturrisi C.E. Jerez E. Methadone assays in pregnant women and progeny Am J Obstet Gynecol 121 1975 617
4. Callahan C.M. Grant T.M. Phipps P. Measurement of gestational cocaine exposure: Sensitivity of infants' hair, meconium, and urine J Pediatr 120 1992 763
5. Chaney N.E. Franke J. Wadlington W.B. Cocaine convulsions in a breast-feeding baby J Pediatr 112 1988 134
6. Chasnoff I.J. Burns W.J. Schnoll S.H. Cocaine use in pregnancy N Engl J Med 313 1985 666
7. Chasnoff I.J. Bussey M.E. Savich R. Perinatal cerebral infarction and maternal cocaine use J Pediatr 108 1986 456
8. Chasnoff I.J. Griffith D.R. MacGregor S. Temporal patterns of cocaine use in pregnancy JAMA 261 1989 1741
9. Coles C.D. Smith I.E. Fernhoff P.M. Neonatal ethanol withdrawal: Characteristics in clinically normal, nondysmorphic neonates J Pediatr 105 1984 445
10. Connaughton J.F. Reeser D. Schut J. Perinatal addiction: Outcome and management Am J Obstet Gynecol 129 1977 679
11. Corwin M.J. Lester B.M. Sepkoski C. Effects of in utero cocaine exposure on newborn acoustical cry characteristics Pediatrics 89 1992 1199
12. Desmond M.M. Schwanecke R.P. Wilson G.S. Maternal barbiturate utilization and neonatal withdrawal symptomatology J Pediatr 80 1972 190
13. Dicker M. Leighton E.A. Trends in diagnosed drug problems among newborns: United States, 1979-1987 Drug Alcohol Depend 28 1991 151
14. Dixon S.D. Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: Incidence and clinical correlates J Pediatr 115 1989 770
15. Doberczak T.M. Kandall S.R. Friedmann P. Relationships between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal Obstet Gynecol 81 1993 936
16. Doberczak T.M. Kandall S.R. Wilets I. Neonatal opiate abstinence syndrome in term and preterm infants J Pediatr 118 1991 933
17. Doberczak T.M. Shanzer S. Senie R.T. Neonatal neurologic and electroencephalo- graphic effects of intrauterine cocaine exposure J Pediatr 113 1988 354
18. Dusick A.M. Covert R.F. Schreiber M.D. Risk of intracranial hemorrhage and other adverse outcomes after cocaine exposure in a cohort of 323 very low birth weight infants J Pediatr 122 1993 438
19. Eisen L.N. Field T.M. Bandstra E.S. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton scale Pediatrics 88 1991 477
20. Eriksson M. Larsson G. Winbladh B. The influence of amphetamine addiction on pregnancy and the newborn infant Acta Paediatr Scand 67 1978 95
21. Eriksson M. Larsson G. Zetterstrom R. Amphetamine addiction and pregnancy Acta Obstet Gynecol Scand 60 1981 253
22. Finnegan L.P. Ehrlich S.M. Maternal drug abuse during pregnancy: Evaluation and pharmacotherapy for neonatal abstinence Mod Methods Pharmacol Testing Eval Drugs of Abuse 6 1990 255
23. Finnegan L.P. Kaltenbach K. Neonatal abstinence syndrome Hoekelman R.A. Friedman S.B. Nelson N Seidel H.M. Primary Pediatric Care ed 2 1992 CV Mosby St. Louis 1367
24. Finnegan L.P. Reeser D.S. Kaltenbach K. Phenobarbital loading dose method for treatment of neonatal abstinence: Effect upon infant development Pediatr Res 13 1979 331
25. Frank D.A. Bauchner H. Parker S. Neonatal body proportionality and body composition after in utero exposure to cocaine and marijuana J Pediatr 117 1990 622
26. Goetz R.L. Bain R.V. Neonatal withdrawal symptoms associated with maternal use of pentazocine J Pediatr 84 1974 887
27. Golden N.L. Sokol R.J. Rubin I.L. Angel dust: Possible effects on the fetus Pediatrics 65 1980 18
28. Gomby D.S. Shiono P.H. Estimating the number of substance-exposed children The Future of Children 1991 Center for the Future of Children Los Altos, CA
29. Harper R.G. Solish G. Feingold E. Maternal ingested methadone, body fluid methadone and the neonatal withdrawal syndrome Am J Obstet Gynecol 129 1977 417
30. Herzlinger R.A. Kandall S.R. Vaughan H.G. Neonatal seizures associated with narcotic withdrawal J Pediatr 91 1977 638
31. Hoyme H.E. Jones K.L. Dixon S.D. Prenatal cocaine exposure and fetal vascular disruption Pediatrics 85 1990 743
32. Kaltenbach K. Finnegan L.P. Neonatal abstinence syndrome, pharmacotherapy and developmental outcome Neurobehav Toxicol Teratol 8 1986 353
33. Kandall S.R. Improving Treatment for Drug-Exposed Infants (Treatment Improvement Protocol Series 1993 Center for Substance Abuse Treatment Rockville, MD 14
34. Kandall S.R. Albin S. Gartner L.M. The narcotic-dependent mother: Fetal and neonatal consequences Early Hum Dev 1977 159 1/2
35. Kandall S.R. Doberczak T.M. Mauer K.R. Opiate v CNS depressant therapy in neonatal drug abstinence syndrome Am J Dis Child 137 1983 378
36. Kandall S.R. Gaines J. Habel L. Relationship of maternal substance abuse to subsequent sudden infant death syndrome in offspring J Pediatr 123 1993 120
37. Kandall S.R. Gartner L.M. Late presentation of drug withdrawal symptoms in newborns Am J Dis Child 127 1974 58
38. King T.A. Perlman J.M. Laptook A.R. Neurologic manifestations of in utero cocaine exposure in near-term and term infants Pediatrics 96 1995 259
39. Kramer L.D. Locke G.E. Ogunyemi A. Neonatal cocaine-related seizures J Child Neurol 5 1990 60
40. Kron R.E. Lift M. Phoenix M.D. Neonatal narcotic abstinence: Effects of pharma- cotherapeutic agents and maternal drug usage on nutritive sucking behavior J Pediatr 88 1976 637
41. Legido A. Clancy R.R. Spitzer A.R. Electroencephalographic and behavioral-state studies in infants of cocaine-addicted mothers Am J Dis Child 146 1992 748
42. Madden J.D. Chappel J.N. Zuspan F. Observation and treatment of neonatal narcotic withdrawal Am J Obstet Gynecol 127 1977 199
43. Mangurten H.H. Neonatal codeine withdrawal in infants of nonaddicted mothers Pediatrics 65 1980 159
44. Mayes L.C. Granger R.H. Frank M.A. Neurobehavioral profiles of neonates exposed to cocaine prenatally Pediatrics 91 1993 778
45. Moore T.R. Sorg J. Miller L. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus Am J Obstet Gynecol 155 1986 883
46. National Pregnancy & Health Survey 1996 0National Institute on Drug Abuse Rockville, MD
47. Oro A.S. Dixon S.D. Perinatal cocaine and methamphetamine exposure: Maternal and neonatal correlates J Pediatr 111 1987 571
48. Oro A.S. Dixon S.D. Waterbed care of narcotic-exposed neonates Am J Dis Child 142 1988 186
49. Ostrea E.M. Brady M. Gause S. Drug screening of newborns by meconium analysis: A large-scale, prospective, epidemiologic study Pediatrics 89 1992 107
50. Ostrea E.M. Chavez C.J. Strauss M.E. A study of factors that influence the severity of neonatal narcotic withdrawal J Pediatr 88 1976 642
51. Petitti D.B. Coleman C. Cocaine and the risk of low birth weight Am J Public Health 80 1990 25
52. Pierog S. Chandavasu O. Wexler I. Withdrawal symptoms in infants with the fetal alcohol syndrome J Pediatr 90 1977 630
53. Pond S.M. Kreek M.J. Tong T.G. Altered methadone pharmacokinetics in methadone-maintained pregnant women J Pharmacol Exp Ther 233 1985 1
54. Preis O. Choi S.J. Rudolph N. Pentazocine withdrawal syndrome in the newborn infant Am J Obstet Gynecol 127 1977 205
55. Prenner B.M. Neonatal withdrawal syndrome associated with hydroxyzine hydrochloride Am J Dis Child 131 1977 529
56. Quillian WW II Dunn C.A. Neonatal drug withdrawal from propoxyphene JAMA 235 1976 2128
57. Rementeria J.L. Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam J Pediatr 90 1977 123
58. Reveri M. Pyati S.P. Pildes R. Neonatal withdrawal symptoms associated with glutethi- mide (Doriden) addiction in the mother during pregnancy Clin Pediatr 16 1977 424
59. Rosen T.S. Pippenger C.E. Pharmacologic observations on the neonatal withdrawal syndrome J Pediatr 88 1976 1044
60. Rumack B.H. Walravens P.A. Neonatal withdrawal following maternal ingestion of ethchlorvynol (Placidyl Pediatrics 52 1973 714
61. Salamy A. Eldredge L. Anderson J. Brain-stem transmission time in infants exposed to cocaine in utero J Pediatr 117 1990 627
62. Scafidi F.A. Field T.M. Wheeden A. Cocaine-exposed preterm neonates show behavioral and hormonal differences Pediatrics 97 1996 851
63. Strauss A.A. Modanlou H.D. Bosu S.K. Neonatal manifestations of maternal phencyclidine (PCP) use Pediatrics 68 1981 550
64. Teske M.P. Trese M.T. Retinopathy of prematurity-like fundus and persistent hyperplastic primary vitreous associated with maternal cocaine use Am J Ophthalmol 103 1987 719
65. Tronick E.Z. Lester B.M. NICU network neurobehavioral scale (NNNS): Refinements in a comprehensive assessment examination of the substance-exposed and high-risk infant NIDA Res Monogr 166 1996 198
66. Tyson H.K. Neonatal withdrawal symptoms associated with maternal use of propoxyphene hydrochloride (Darvon) J Pediatr 85 1974 684
67. Weinberger S.M. Kandall S.R. Doberczak T.M. Early weight-change patterns in neonatal abstinence Am J Dis Child 140 1986 829
68. Woods J.R. Plessinger M.A. Clark K.E. Effect of cocaine on uterine blood flow and fetal oxygenation JAMA 257 1987 957